This year's Annual Meeting of BIORIMA was organized as a virtual meeting including a dedicated session on "BIORIMA response to COVID-19".
In these times, when COVID-19 is still challenging the world, we all have opportunities to step back and see things from a different perspective. And indeed, many of us are experiencing this pandemic not only as a challenge, but also as a time for change and renewal, be it on the political, socioeconomic or personal level, and in particular related to our existing safety and health care systems.
This forum is a discussion platform for relevant stakeholders and end-users to reach out to the project, to directly contact the expert, and to share and discuss your views and requirements.
Successful BIORIMA Consortium Meeting held in Rome, Italy.
The BIORIMA project was part of the joint NanoSafety Cluster booth at the 9th edition of EuroNanoForum.
In the light of increasing regulatory demands on the use of medical devices (MD) and advanced therapeutic medicinal products (ATMP), the EU funded BIORIMA project has taken a lead in developing an integrated risk management framework for the safe handling of nano-biomaterials (NBM) used in these medical applications. For the first time, it will be possible to assess and manage various risks that may arise from manufacturing and use of these novel materials along their life cycle and beyond clinical risks.
In the portuguese book "Women in Science" they pay tribute to Portuguese scientists who are considered to have contributed in some special way to knowledge progress
The second edition of a series of Training Schools organised within the EU funded Horizon 2020 projects BIORIMA, GRACIOUS and NanoInformaTIX took place in the historic center of Venice, Italy on 25-29 March 2019.
“Integration” was the underlying keyword of the 1st BIORIMA Stakeholder Workshop, which was held in the beautiful Spanish city of Valencia on November 6th 2018.